Overview
No overview information available.
Indication
用于脑血管疾病及脑动脉硬化、脑外伤或脑卒中后遗症、大脑发育不全、老年性痴呆以及记忆力减退者。
Associated Conditions
- Alzheimer's Disease (AD)
- Cerebrovascular Diseases
- Craniocerebral Injuries
- Stroke
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/11/06 | Not Applicable | ENROLLING_BY_INVITATION | |||
2024/07/08 | Early Phase 1 | Not yet recruiting | University Hospital "Sestre Milosrdnice" | ||
2024/04/01 | Early Phase 1 | Not yet recruiting | Chang Gung Memorial Hospital | ||
2024/02/22 | Phase 4 | Recruiting | Hospital Universitario Dr. Jose E. Gonzalez | ||
2024/01/17 | Phase 4 | Completed | Sherifa Ahmed Hamed | ||
2023/10/06 | Not Applicable | Recruiting | |||
2023/09/25 | Phase 3 | Recruiting | |||
2023/05/18 | Not Applicable | ENROLLING_BY_INVITATION | |||
2023/04/20 | Phase 1 | Recruiting | |||
2023/04/11 | N/A | Completed | Pomeranian Medical University Szczecin |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.